NFKB1 and psoriasis: These findings strongly suggest that 4GMV could alleviate psoriasis in IMQ-induced psoriasis-like mice and inhibit inflammatory cytokines through suppressing the activation of TLR4-mediated NF-κB and MAPKs signaling pathways, which might represent a novel strategy for psoriasis treatment.